Novel swine model developed for neurofibromatosis type 1

Recombinetics (RCI), a pioneer in gene editing and applied technologies in biomedicine and agriculture, announced the development of first-in-class gene-edited swine models for Neurofibromatosis Type 1 (NF1), a multi-system human genetic disorder that causes tumors to develop along the nervous system.